RBC Bearings Beats Expectations, Hologic Receives FDA Clearance, Cantor Fitzgerald Bullish on Bitfarms
- May 19th, 2023
- 644 views
RBC Bearings Incorporated (NYSE: RBC) has released its fourth-quarter fiscal 2023 earnings report, surpassing consensus expectations. The company reported an EPS of $2.13, exceeding the consensus estimate of $1.99.
In pre-market, $RBC is currently trading at $228.01, experiencing a notable increase of $3.67 (+1.64%).
Hologic Inc. (Nasdaq: HOLX) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Panther Fusion SARS-CoV-2/Flu A/B/RSV assay. This molecular diagnostic test can detect and differentiate four of the most common respiratory viruses, namely severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A (flu A), influenza B (flu B), and respiratory syncytial virus (RSV).
Following the announcement, $HOLX is trading at $82.45 in pre-market, reflecting an increase of $1.39 (+1.71%).
Bitfarms Ltd. (Nasdaq: BITF) has been initiated with an Overweight rating and a price target of $2 by Cantor Fitzgerald.
$BITF is currently trading at $1.20 in pre-market, showing a rise of $0.05 (+4.35%).
Please note that the stock prices and pre-market movements mentioned here are for illustrative purposes and may not reflect the current market conditions at the time of reading.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
NJCP Football League Provides Development and Opportunity for Athletes Pursuing the Next Level
March 20th, 2026March 19th, 2026How High School Graduates Can Kickstart Their Football Career
March 18th, 2026




Member Login